Abstract
C.M.Wischik, D.J. Wischik, J.M.D.Storey, C.R.Harrington
The present invention relates generally to methods and materials for use in the treatment or prophylaxis of diseases, for example cognitive disorders, using diaminophenothiazines. In particular it relates to treatments having optimised pharmacokinetic properties, and dosage forms are intended to improve the relative cognitive or CNS benefits of the diaminophenothiazines, for instance compared to haematological effects.
The present invention relates generally to methods and materials for use in the treatment or prophylaxis of diseases, for example cognitive disorders, using diaminophenothiazines. In particular it relates to treatments having optimised pharmacokinetic properties, and dosage forms are intended to improve the relative cognitive or CNS benefits of the diaminophenothiazines, for instance compared to haematological effects.
| Original language | English |
|---|---|
| IPC | WO2009/044127 |
| Publication status | Published - 9 Apr 2009 |
Fingerprint
Dive into the research topics of 'Therapeutic Use of Diaminophenothiazines: WO2009044127'. Together they form a unique fingerprint.Impacts
-
Development of treatments & diagnostics for Alzheimer’s disease
Storey, J. (Coordinator)
Impact: Other Impacts
-
Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Wischik, C. (Participant), Harrington, C. (Participant), Storey, J. (Participant), (Participant), Horsley, D. (Participant), Baddeley, T. (Participant), Kemp, S. (Participant), Sinclair, J. (Participant), (Participant), Theuring, F. (Participant), Stamer, F. (Participant) & Marshall, C. (Participant)
Impact: Health and Wellbeing, Economic and/or Commercial